Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction.

Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction. Abstract Text:

Atrial natriuretic peptide (ANP) is a member of the natriuretic peptide family that exerts various biological effects via acting on the receptor-guanylyl cyclase system, increasing the content of intracellular cyclic guanosine monophosphate (cGMP). ANP was first identified as a diuretic/natriuretic and vasodilating hormone, but subsequent studies revealed that ANP has a very important function in the inhibition of the renin-angiotensin-aldosterone system (RAAS), endothelin synthesis, and sympathetic nerve activity. Evidence is also accumulating from recent work that ANP exerts its cardioprotective functions not only as a circulating hormone but also as a local autocrine and/or paracrine factor. ANP inhibits apoptosis and hypertrophy of cardiac myocytes, and inhibits proliferation and fibrosis of cardiac fibroblasts. Reperfusion of the ischaemic myocardium by percutaneous coronary intervention (PCI) reduces the infarct size and improves left ventricular (LV) function in patients with acute myocardial infarction (AMI). However, the benefits of PCI in AMI are limited by reperfusion injury. Animal studies have shown that ANP inhibits ischaemia/reperfusion injury, and reduces infarct size. We and others have recently shown that the intravenous administration of ANP inhibits RAAS, sympathetic nerve activity and reperfusion injury, prevents LV remodelling, and improves LV function in patients with AMI. ANP has a variety of cardioprotective effects and is considered to be a very promising adjunct drug for the reperfusion therapy in patients with AMI.

Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: European heart journal

VOLUME: 29

Page Numbers: 1485-94

Journal Abbreviation: Eur. Heart J.

ISSN: 1522-9645

DAY: 19

MONTH: 05

YEAR: 2008

Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8006263

Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction.

AFFILIATION: Department of Cardiovascular Medicine, Gunma University School of Medicine, 3-39-15 Showa-machi, Maebashi, Gunma 371-0034, Japan. s-kasama@bay.wind.ne.jp

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Eur Heart J

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction Related Publications

• A potential pitfall of MR imaging for assessing mandibular invasion of squamous cell carcinoma in the oral cavity.
• Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.
• An investigation of magnetic resonance imaging features in 14 patients with synovial chondromatosis of the temporomandibular joint.
• Changes in horizontal jaw position and intraoral pressure.
• Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction.
• Effects of aging, menopause, and hormone replacement therapy on forearm skin elasticity in women.
• Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
• Imaging of epithelial cancer in sub-terahertz electromagnetic wave.
• Insulin Resistance in Patients with Stroke is Related to Visceral Fat Obesity and Adipocytokines.
• Lentiviral Vector-mediated SERCA2 Gene Transfer Protects Against Heart Failure and Left Ventricular Remodeling After Myocardial Infarction in Rats.
• Long-term nicorandil therapy improves cardiac sympathetic nerve activity after reperfusion therapy in patients with first acute myocardial infarction.
• MRI and clinical findings of posterior disk displacement in the temporomandibular joint.
• MRI findings of temporomandibular joints with disk perforation.
• Mechanisms and clinical implications of asymptomatic mitral regurgitation in patients with left ventricular dysfunction.
• Network structure for control of coupled multiple nonlinear oscillators.
• Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure.
• Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
• Prostaglandin F(2alpha) Inhibits SERCA2 Gene Transcription Through an Induction of Egr-1 in Cultured Neonatal Rat Cardiac Myocytes.
• Relationship between Carotid Atherosclerosis and Lumbar Spine Bone Mineral Density in Postmenopausal Women.
• Relationship between brachial arterial endothelial function and lumbar spine bone mineral density in postmenopausal women.
• Relationship between metabolic syndrome and sleep-disordered breathing in patients with cardiovascular disease--metabolic syndrome as a strong factor of nocturnal desaturation.
• Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells.
• [A case of HLA-DR8 positive sarcoidosis following polymyositis and Sjögren's syndrome]
• [A case of Wegener's granulomatosis associated with the syndrome of inappropriate secretion of ADH]
• [A case of allergic bronchopulmonary aspergillosis that itraconazole showed a definite effect temporarily]
• [A case of anaphylactoid purpura associated with nephrosis followed by pulmonary tuberculosis]
• [A case of small cell lung carcinoma complicated by Lambert-Eaton myasthenic syndrome]
• [New evidence of conjugated estrogen and 17beta-estradiol]
• [Oxidative stress and mild hypertension]